emricasan

Conatus to Slash Staff, Consider Sale After NASH Trial Failures
Xconomy
Tue, 06/25/19 - 09:13 am
Conatus Pharmaceuticals
NASH
layoffs
emricasan
Conatus Pharma to explore options as liver disease drug fails trial
Yahoo/Reuters
Mon, 06/24/19 - 07:20 pm
Conatus Pharmaceuticals
clinical trials
NASH
emricasan
Novartis
Conatus and Novartis suffer another midphase NASH flop
Fierce Biotech
Fri, 03/22/19 - 11:51 am
Conatus
Novartis
NASH
emricasan
clinical trials
Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan
Yahoo/Zacks.com
Thu, 03/21/19 - 09:47 am
Conatus
emricasan
NASH
Novartis’ partners at Conatus have another NASH setback to confess today
Endpoints
Wed, 12/5/18 - 07:43 pm
Novartis
Conatus
emricasan
cirrhosis
NASH
clinical trials
Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test
Xconomy
Thu, 04/5/18 - 11:57 pm
Conatus Pharmaceuticals
clinical trials
Novartis
emricasan
liver disease
hepatitis C
Conatus: Emricasan's 4 Indications Present A Lucrative Opportunity In The Liver Disease Market
Seeking Alpha
Sat, 07/18/15 - 10:48 am
Conatus Pharmaceuticals
emricasan
liver disease
NASH
cirrhosis
Conatus Pharmaceuticals Presents Data Demonstrating Emricasan's Safety Profile at the AASLD Liver Meeting(R)
Yahoo/Globe Newswire
Sat, 11/2/13 - 11:31 am
emricasan
Conatus Pharmaceuticals
Does Conatus Pharmaceuticals Have A Winner With Emricasan?
Seeking Alpha
Thu, 09/26/13 - 08:12 am
Conatus Pharmaceuticals
emricasan
Gilead
Merck
Pfizer
liver disease
Sunesis
apoptosis